CNF-RNTModulating Repetitive Negative Thinking Related Brain Networks in Young Adults With Depression
Active neurofeedback
+ Sham neurofeedback
Mental Disorders+1
+ Depressive Disorder, Major
+ Depressive Disorder
Basic Science Study
Summary
Study start date: January 12, 2024
Actual date on which the first participant was enrolled.This study focuses on young adults aged 18 to 25 who suffer from major depressive disorder (MDD). One in ten young adults are affected by MDD, which can lead to serious consequences like related mental disorders, unemployment, and even suicide. The study aims to explore a new approach to treatment by targeting repetitive negative thinking (RNT), a common issue in MDD where individuals struggle to control distressing thoughts. Current treatments such as medication and therapy often have limited success, particularly for those with high levels of RNT. By using real-time functional Magnetic Resonance Imaging neurofeedback (rtfMRI-nf), the study seeks to understand and potentially modify the brain activity associated with these distressing thought patterns, which could lead to better recovery outcomes for those with MDD. Participants in this study will undergo a non-invasive brain imaging technique that provides real-time feedback on their brain activity. The study involves 110 young adults with MDD and high levels of RNT, who will be randomly assigned to receive either real feedback on their brain activity or sham feedback that does not relate to their brain activity. This will be done during a self-regulation task across two visits one week apart. The primary goal is to see if the real feedback can reduce abnormal brain connectivity linked to RNT, potentially decreasing the severity of negative thinking and depression. The study will measure changes in brain connectivity and evaluate the impact on depression and negative thinking severity using established rating scales.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.54 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Basic Science Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 35 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
ShamStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Laureate Institute for Brain Research
Tulsa, United StatesOpen Laureate Institute for Brain Research in Google Maps